Hims & Hers to launch a generic for Novo’s older GLP-1
Hims & Hers Health (NYSE:HIMS) is gearing up to launch an off-patent version of Novo Nordisk's (NVO) (OTCPK:NONOF) older GLP-1 weight loss therapy liraglutide in 2025, CEO of the telehealth platform ...
kffhealthnews15h
Lawsuits Say GoodRx, PBMs Quash Reimbursements To Small Pharmacies
CVS Caremark and Express Scripts, along with GoodRx and others, are accused of working together to suppress reimbursements to independent pharmacies in at least three class-action lawsuits. Also, Hims ...
Stocktwits on MSN19h
Hims & Hers Soars Pre-Market After Analysts Boost Price Targets On Strong Q3 Performance
Hims & Hers Health Inc. ($HIMS) rallied nearly 9% in pre-market trading on Tuesday, following the company’s third-quarter ...
Seeking Alpha3h
Novo Nordisk: A GLP-1 Leader Faces Increasing Competition
Hims & Hers anticipates selling a generic version of NVO's liraglutide, threatening sales as soon as next year. Intense ...
Morningstar1d
Hims & Hers Health Inc Ordinary Shares - Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Business Insider6d
Hims & Hers falls -14.6%
Hims & Hers (HIMS) is down -14.6%, or -$3.25 to $19.00. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks ...
Fatty Liver Disease: What Men Need to Know
Fatty liver disease happens when fat builds up in your liver. This can cause damage, inflammation, and other complications.
California Healthline2mon
California Healthline Daily Edition
Whoever wins the presidency, the 2024 election has outsized implications for California. The elevation of Democratic Vice President Kamala Harris to the highest office in the land would make her the ...